Lamotrigine and Nucynta drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Lamotrigine (lamotrigine) and Nucynta (tapentadol hydrochloride). Common drug interactions include blood potassium decreased among females and fall among males.

The phase IV clinical study analyzes what interactions people have when they take Lamotrigine and Nucynta. It is created by eHealthMe based on reports of 74 people who take the same drugs from the FDA, and is updated regularly.

What is Lamotrigine?

Lamotrigine has active ingredients of lamotrigine. It is often used in bipolar disorder. eHealthMe is studying from 76,638 Lamotrigine users. Check the latest studies of Lamotrigine.

What is Nucynta?

Nucynta has active ingredients of tapentadol hydrochloride. It is often used in pain. eHealthMe is studying from 31,818 Nucynta users. Check the latest studies of Nucynta.



On Aug, 12, 2026

74 people who take Lamotrigine and Nucynta together, and have interactions are studied.

Lamotrigine and Nucynta drug interactions.

What are the common drug interactions of Lamotrigine and Nucynta, by gender? *:

female:

  1. Blood potassium decreased
  2. Blood pressure decreased
  3. Blood pressure increased
  4. Feeling of despair
  5. Hysterectomy
  6. Intervertebral disc degeneration (spinal disc degeneration)
  7. Kidney infection
  8. Limb injury
  9. Major depression (a mood state that goes well beyond temporarily feeling sad or blue. it is a serious medical illness that affects one's thoughts, feelings)
  10. Psychiatric symptom

male:

  1. Fall
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Loss of consciousness
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Muscle spasms (muscle contraction)
  6. Renal failure (kidney dysfunction)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  9. Diarrhoea
  10. Hypersomnia (excessive daytime sleepiness (eds))

What are the common drug interactions of Lamotrigine and Nucynta, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

  1. Insomnia (sleeplessness)
  2. Palpitations (feelings or sensations that your heart is pounding or racing)
  3. Supraventricular tachycardia (rapid heart rhythm originating at or above the atrioventricular node)
  4. Tremor (trembling or shaking movements in one or more parts of your body)

30-39:

  1. Abnormal behaviour

40-49:

  1. Drug ineffective
  2. General physical health deterioration (weak health status)
  3. Suicidal ideation
  4. Borderline personality disorder
  5. Cervical spinal stenosis (narrowing of the spinal canal in the neck)
  6. Depression
  7. Intervertebral disc protrusion (spinal disc protrusion)
  8. Myalgia (muscle pain)
  9. Disability
  10. Fatigue (feeling of tiredness)

50-59:

  1. Joint swelling
  2. Anxiety
  3. Arthropathy
  4. Burning sensation
  5. Chronic kidney disease
  6. Drug ineffective
  7. Gastrooesophageal reflux disease (stomach contents (food or liquid) leak backwards from the stomach into the oesophagus)
  8. Nodule (a growth of abnormal tissue)
  9. Oedema peripheral (superficial swelling)
  10. Osteoarthritis (a joint disease caused by cartilage loss in a joint)

60+:

  1. Fall
  2. Chronic obstructive pulmonary disease (a progressive disease that makes it hard to breathe)
  3. Loss of consciousness
  4. Mental disorder (a psychological term for a mental or behavioural pattern or anomaly that causes distress or disability)
  5. Muscle spasms (muscle contraction)
  6. Renal failure (kidney dysfunction)
  7. Cerebral ischaemia (insufficient blood flow to the brain to meet metabolic demand)
  8. Demyelination (loss of the myelin covering of some nerve fibres resulting in their impaired function)
  9. Diarrhoea
  10. Hypersomnia (excessive daytime sleepiness (eds))

What are the existing conditions these people have? *

  1. Narcolepsy (brain's inability to regulate sleep-wake cycles normally): 32 people, 43.24%
  2. Cataplexy (loss of muscle tone accompanied by full conscious awareness): 18 people, 24.32%
  3. Stress And Anxiety: 12 people, 16.22%
  4. Depression: 11 people, 14.86%
  5. High Blood Pressure: 10 people, 13.51%
  6. Fibromyalgia (a long-term condition which causes pain all over the body): 10 people, 13.51%
  7. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 8 people, 10.81%
  8. Nausea (feeling of having an urge to vomit): 7 people, 9.46%
  9. High Blood Cholesterol: 6 people, 8.11%
  10. Migraine (headache): 5 people, 6.76%

* Approximation only. Some reports may have incomplete information.

Do you take Lamotrigine and Nucynta?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Lamotrigine and Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Lamotrigine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Nucynta:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Lamotrigine and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Nucynta and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on lamotrigine and tapentadol hydrochloride (the active ingredients of Lamotrigine and Nucynta, respectively), and Lamotrigine and Nucynta (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: